Literature DB >> 9744676

Exploring the combined action of lifetime alcohol intake and chronic hepatotropic virus infections on the risk of symptomatic liver cirrhosis. Collaborative Groups for the Study of Liver Diseases in Italy.

G Corrao1, P Torchio, A Zambon, P Ferrari, S Aricò, F di Orio.   

Abstract

Although alcohol intake and hepatitis B and C virus (HBV and HCV) infections are the major determinants of liver cirrhosis (LC) in western countries, the joint effect of these factors on LC risk has not yet been adequately studied. Data from three case-control studies performed in Italy were used. Cases were 462 cirrhotic patients admitted to Hospitals for liver decompensation. Controls were 651 inpatients admitted for acute diseases unrelated to alcohol. Alcohol consumption was expressed as lifetime daily alcohol intake (LDAI). Three approaches were used to explore the interaction structure. The Breslow and Storer parametric family of relative risk functions showed that an intermediate structure of interaction from additive to multiplicative was the most adequate one. The Rothman synergism index showed that the interaction structure between LDAI and viral status differed significantly from the additive model in particular for high levels of alcohol intake. When multiple regression additive and multiplicative models were compared after adjustment for the known confounding variables. a trend of the interaction structure towards the multiplicative model was observed at increasing levels of consumption. Better methods are needed for assessing mixed interaction structures in conditions characterized by multifactorial etiologies like cirrhosis of the liver.

Entities:  

Mesh:

Year:  1998        PMID: 9744676     DOI: 10.1023/a:1007411423766

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  46 in total

1.  Hepatitis C viremia and anti-HCV antibodies in alcoholics.

Authors:  B Nalpas; V Thiers; S Pol; F Driss; V Thepot; P Berthelot; C Brechot
Journal:  J Hepatol       Date:  1992-03       Impact factor: 25.083

2.  The estimation of synergy or antagonism.

Authors:  K J Rothman
Journal:  Am J Epidemiol       Date:  1976-05       Impact factor: 4.897

3.  Chronic hepatitis C in alcoholic patients: studies with various HCV assay procedures.

Authors:  K Ishii; S Furudera; S Tanaka; R Kumashiro; M Sata; H Abe; K Tanikawa
Journal:  Alcohol Alcohol Suppl       Date:  1993

4.  Alcohol and hepatitis B virus infection.

Authors:  E Villa; G Baldini; S Di Stabile; C Pasquinelli; A Antonioli; M Plessi; D Braghiroli; T Barchi; A Monzani; F Manenti
Journal:  Acta Med Scand Suppl       Date:  1985

5.  General relative risk functions for case-control studies.

Authors:  N E Breslow; B E Storer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

6.  Alcohol consumption and non-cirrhotic chronic hepatitis: a case-control study.

Authors:  G Corrao; S Arico; R Russo; F Carle; G Galatola; P F Torchio; A R Moiraghi; F di Orio; M de la Pierre
Journal:  Int J Epidemiol       Date:  1991-12       Impact factor: 7.196

7.  Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan.

Authors:  J F Tsai; W Y Chang; J E Jeng; M S Ho; L Y Wang; M Y Hsieh; S C Chen; W L Chuang; Z Y Lin; J H Tsai
Journal:  J Med Virol       Date:  1993-12       Impact factor: 2.327

8.  Hepatitis B and hepatitis C virus infection among chronic alcoholic patients with liver disease in Taiwan.

Authors:  T T Chang; C Y Lin; N H Chow; P I Hsu; C C Yang; X Z Lin; J S Shin; D S Chen
Journal:  J Formos Med Assoc       Date:  1994-02       Impact factor: 3.282

9.  Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease.

Authors:  M E Coelho-Little; L J Jeffers; D E Bernstein; J J Goodman; K R Reddy; M de Medina; X Li; M Hill; S La Rue; E R Schiff
Journal:  Alcohol Clin Exp Res       Date:  1995-10       Impact factor: 3.455

10.  An epidemiologic study of effects of alcohol in the liver in hepatitis B surface antigen carriers.

Authors:  H Nomura; S Kashiwagi; J Hayashi; W Kajiyama; H Ikematsu; A Noguchi; S Tani; M Goto
Journal:  Am J Epidemiol       Date:  1988-08       Impact factor: 4.897

View more
  5 in total

1.  Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinoma.

Authors:  Yun-Hsuan Lee; Chia-Yang Hsu; Cheng-Yuan Hsia; Yi-Hsiang Huang; Chien-Wei Su; Yi-You Chiou; Han-Chieh Lin; Teh-Ia Huo; Shou-Dong Lee
Journal:  Hepatol Int       Date:  2012-05-17       Impact factor: 6.047

2.  Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physicians.

Authors:  Ashwani K Singal; Habeeb Salameh; Anjna Singal; Sarat C Jampana; Daniel H Freeman; Karl E Anderson; Don Brunder
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-05-06

Review 3.  Systematic review of the pharmacological treatment of alcohol use disorders in individuals infected with hepatitis C.

Authors:  Alexis Thibault; Suzanne Brissette; Didier Jutras-Aswad
Journal:  Addict Sci Clin Pract       Date:  2015-02-24

4.  Etiology of liver cirrhosis in Brazil: chronic alcoholism and hepatitis viruses in liver cirrhosis diagnosed in the state of Espírito Santo.

Authors:  Patricia Lofego Gonçalves; Maria da Penha Zago-Gomes; Carla Couzi Marques; Ana Tereza Mendonça; Carlos Sandoval Gonçalves; Fausto Edmundo Lima Pereira
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

5.  Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa.

Authors:  Mark H Kuniholm; Olufunmilayo A Lesi; Maimuna Mendy; Aliu O Akano; Omar Sam; Andrew J Hall; Hilton Whittle; Ebrima Bah; James J Goedert; Pierre Hainaut; Gregory D Kirk
Journal:  Environ Health Perspect       Date:  2008-07-10       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.